Skip to Main Content

2,776

Views

5

CrossRef citations to date

0

Altmetric

Reports

Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model

Parul Guptaa Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USA;b Biomedicine Design, Pfizer Inc., San Diego, CA, USAView further author information

,

Ziyue Karen Jianga Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information

,

Bing Yanga Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information

,

Lisa Manzuka Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information

,

Edward Rosfjordc Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information

,

Johnny Yaoc Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information

,

Luanna Lemonc Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information

,

Kavon Noorbeheshta Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information

,

John Davida Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USAView further author information

,

Sujiet Puthenveetild Medicinal Sciences, Pfizer Incorporated, San Diego, CA, USAView further author information

,

Jeffrey M. Casavantd Medicinal Sciences, Pfizer Incorporated, San Diego, CA, USAView further author information

,

Elwira Muszynskac Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information

,

Fengping Lib Biomedicine Design, Pfizer Inc., San Diego, CA, USAView further author information

,

Mauricio Lealb Biomedicine Design, Pfizer Inc., San Diego, CA, USAView further author information

,

Puja Saprac Oncology Research and Development, Pfizer Inc., Pearl River, NY, USAView further author information

&

Anand Giddabasappaa Global Science & Technology – Comparative Medicine, Pfizer Inc., San Diego, CA, USACorrespondence[email protected]

https://orcid.org/0000-0002-1546-2481 View further author information